Consensus EPS · Q2 2026
$0.47
Consensus revenue · Q2 2026
$769.5M
Analysts
9
Expected report
Jul 29, 2026
What to watch
- Analyst ratings: Mixed
Analyst consensus
Based on estimates from 9 analysts.
| Metric | Low | Consensus | High |
|---|---|---|---|
| Revenue | $747M | $769.5M | $785M |
| EPS | $0.45 | $0.47 | $0.49 |
| EBITDA | $509.5M | $525M | $536M |
| EBIT | $509.5M | $525M | $536M |
| Net income | $325.1M | $339.6M | $346.8M |
- Revenue$769.5M
- EPS$0.47
- EBITDA$525M
- EBIT$525M
- Net income$339.6M
Historical beat/miss
Actual reported results vs. analyst consensus at the time. Positive = beat, negative = miss.
| Period | Rev. actual | Rev. est. | Rev. surprise | EPS actual | EPS est. | EPS surprise |
|---|---|---|---|---|---|---|
| Q1 2026 | $763M | $778M | -1.9% | $0.47 | $0.48 | -2.6% |
- Q1 2026-1.9%-2.6%
Estimate revisions
How analyst consensus estimates have changed over the past 90 days.
Revision trends appear once we have collected at least two daily snapshots for this period.
Community vs analysts
See how the TickerLeague crowd's forecast stacks up against Wall Street.
Be the first to predict
No community consensus for Ares Capital (ARCC) Q2 2026 yet. Make a prediction to start the crowd forecast.
Analyst price target
Based on price targets from 0 analysts.
- Low
- $19.00
- Consensus
- $19.00
- Median
- $19.00
- High
- $19.00
- Current
- $18.86
- Upside
- +0.7%
Upside calculated vs most recent trading price of $18.86.
Analyst ratings
Consensus: Buy — based on 32 analyst ratings.
24-month trend
Recent analyst actions
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jul 2, 2026 | JP Morgan | maintain | Overweight | Overweight |
| Jun 12, 2026 | Wells Fargo | downgrade | Overweight | Equal Weight |
| Apr 29, 2026 | Truist Securities | maintain | Buy | Buy |
| Apr 29, 2026 | RBC Capital | maintain | Outperform | Outperform |
| Apr 22, 2026 | Citizens | maintain | Market Outperform | Market Outperform |
| Apr 16, 2026 | Keefe, Bruyette & Woods | maintain | Outperform | Outperform |
| Mar 13, 2026 | UBS | maintain | Neutral | Neutral |
| Mar 13, 2026 | JP Morgan | maintain | Overweight | Overweight |
| Feb 9, 2026 | RBC Capital | maintain | Outperform | Outperform |
| Feb 5, 2026 | Wells Fargo | maintain | Overweight | Overweight |
- Jul 2, 2026JP MorganOverweight
- Jun 12, 2026Wells FargoEqual Weight
- Apr 29, 2026Truist SecuritiesBuy
- Apr 29, 2026RBC CapitalOutperform
- Apr 22, 2026CitizensMarket Outperform
- Apr 16, 2026Keefe, Bruyette & WoodsOutperform
- Mar 13, 2026UBSNeutral
- Mar 13, 2026JP MorganOverweight
- Feb 9, 2026RBC CapitalOutperform
- Feb 5, 2026Wells FargoOverweight
Frequently asked questions
Ares Capital (ARCC) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
How this company returns cash to shareholders — buybacks, dividends, and stock splits.